Evaluating the Therapeutic Efficacy of NAD Supplementation in Management of MASLD: Key Considerations

Clin Mol Hepatol. 2023 Dec 29. doi: 10.3350/cmh.2023.0555. Online ahead of print.

Authors

Xinyi Lu^{1

2}, Rui Yang², Yu Chen², Daozhen Chen^{1

2

3}

Affiliations

¹ Wuxi Medical Center, Nanjing Medical University, Jiangsu, 211166, China.
² Wuxi Maternal and Child Health Hospital,Wuxi School of Medicine, Jiangnan University, Jiangsu, 214002, China.
³ Department of Laboratory, Haidong Second People's Hospital, Haidong, 810699, China.

PMID: 38163440
DOI: 10.3350/cmh.2023.0555

No abstract available

Keywords: Fecal microbiota transplantation; Metabolic Dysfunction-Associated Steatotic Liver Disease; NAD metabolism; Metabolic therapy.